Two Years of Cancer Research Communications: A Conversation with the Journal’s Editors-in-Chief
In 2021, Lillian L. Siu, MD, and Elaine R. Mardis, PhD, FAACR, each received a call from AACR Chief...
Category: SU2C
In 2021, Lillian L. Siu, MD, and Elaine R. Mardis, PhD, FAACR, each received a call from AACR Chief...
A long and fruitful partnership in the world of cancer research began in 2006 in Hollywood with AACR CEO...
Multiple myeloma arises in immune cells called plasma cells. It is one of the most commonly diagnosed hematological malignancies...
In 1993, Jon R. Katzenbach and Douglas K. Smith authored The Wisdom of Teams, a collection of observations and...
Pancreatic cancer is a deadly disease with a five-year survival rate of a mere 8.2 percent, according to statistics...
As we learned recently, Senator John McCain was diagnosed with glioblastoma multiforme, an aggressive form of central nervous system...
Stand Up To Cancer’s highly successful 2016 fundraising telecast will help keep up the pace of progress against cancer,...
We observe May as National Cancer Research Month to celebrate the tremendous advances that have been made in our...
AACR is the proud Scientific Partner for Stand Up To Cancer (SU2C), and for Colorectal Cancer Awareness Month, we...
Guest Post by Alan D. D’Andrea, MD, and Elizabeth M. Swisher, MD SU2C-OCRF-OCNA-NOCC Dream Team